Skip to Main Content
Table 4—

RH (95% CI) for all-cause and CVD mortality by 1997 ADA and 1998 WHO criteria for 3,092 adults aged 30–74 years in NHANES II

Normal glucose toleranceImpaired fasting glucoseUndiagnosed diabetesDiagnosed diabetes
ADA 
n 2,706 193 97 96 
 All-cause     
  RH (95% CI) Reference 1.08 (0.70–1.67) 1.41 (0.77–2.58) 1.86 (1.03–3.15) 
 CVD     
  RH (95% CI) Reference 0.65 (0.31–1.34) 1.23 (0.49–3.07) 1.70 (1.02–2.84) 
WHO 
n 2,226 555 215 96 
 All-cause 
  RH (95% CI) Reference 1.14 (0.80–1.63) 1.36 (0.84–2.21) 1.89 (1.07–3.36) 
 CVD     
  RH (95% CI) Reference 0.93 (0.57–1.51) 1.21 (0.62–2.39) 1.76 (1.03–3.01) 
Normal glucose toleranceImpaired fasting glucoseUndiagnosed diabetesDiagnosed diabetes
ADA 
n 2,706 193 97 96 
 All-cause     
  RH (95% CI) Reference 1.08 (0.70–1.67) 1.41 (0.77–2.58) 1.86 (1.03–3.15) 
 CVD     
  RH (95% CI) Reference 0.65 (0.31–1.34) 1.23 (0.49–3.07) 1.70 (1.02–2.84) 
WHO 
n 2,226 555 215 96 
 All-cause 
  RH (95% CI) Reference 1.14 (0.80–1.63) 1.36 (0.84–2.21) 1.89 (1.07–3.36) 
 CVD     
  RH (95% CI) Reference 0.93 (0.57–1.51) 1.21 (0.62–2.39) 1.76 (1.03–3.01) 

Participants with impaired fasting glucose (defined as 2-h glucose <7.8 mmol/l and fasting glucose ≥6.1 and <7.0 mmol/l) (n = 76) were excluded from the analysis because of small numbers. There were 26 deaths among these participants.

*

Adjusted for age (continuous), sex, race (white, non-white), education (<high school, ≥high school), smoking (ever, never), physical activity (low, high), BMI (<25, 25≤ to <27, 27≤ to <30, ≥30 kg/m2), systolic blood pressure, total cholesterol–to–HDL cholesterol ratio (continuous).

Close Modal

or Create an Account

Close Modal
Close Modal